Quatsuv

We develop new nanomedicine candidates based on small unilamellar vesicles (SUVs) and nanoliposomes, as new drug delivery systems with tailored properties, including biocompatibility, size, structure, addresability, and functionality. Our DELOS-SUSP technology is a simple one-step procedure to prepare this kind of multifunctional disperse systems in a highly homogeneous and reproducible way. DELOS-SUSP nanovesicles have outstanding structural characteristics, non achievable by conventional preparation routes, such as the thin-film hydration, widely used at lab scale. DELOS-SUSP process is readily scalable to produce nanopharmaceuticals for therapeutic applications.

Quatsuvs consist of nanovesicles formed by Self-Assembly of Sterols and Quaternary Ammonium Surfactants Salts easy produced by DELOS-SUSP. These colloidal structures have a broad range of applications in pharmacy, cosmetics, and materials because:

  • QUATSUVS are stable for periods as long as several years;
  • QUATSUV morphologies and physico-chemical properties do not change upon rising temperature or dilution
  • DELOS-SUSP is a green, robust and easy scalable productive process under GMP requirements
  • QUATSUVS provide efficient integration of actives (APIs and biomolecules) and easy functionalization
  • DELOS and QUATSUVS are enabling technologies for topical, inhalation and parenteral delivery routes
quatsuv
quatsuv 2